INGREZZA
These highlights do not include all the information needed to use INGREZZA safely and effectively. See full prescribing information for INGREZZA. INGREZZA (valbenazine) capsules, for oral use Initial U.S. Approval: 2017
4c970164-cafb-421f-9eb5-c226ef0a3417
HUMAN PRESCRIPTION DRUG LABEL
Aug 18, 2023
Neurocrine Biosciences, Inc.
DUNS: 800981276
Products 5
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Valbenazine
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (9)
Valbenazine
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (9)
Valbenazine
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
Valbenazine
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (9)
Valbenazine
Product Details
FDA regulatory identification and product classification information